Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 4
1978 2
1979 3
1980 4
1981 4
1982 5
1983 1
1984 1
1985 1
1986 1
1987 3
1988 4
1989 6
1990 3
1991 10
1992 6
1993 10
1994 11
1995 9
1996 4
1997 8
1998 11
1999 11
2000 4
2001 8
2002 3
2003 13
2004 9
2005 12
2006 13
2007 12
2008 10
2009 12
2010 14
2011 16
2012 12
2013 16
2014 19
2015 8
2016 13
2017 21
2018 13
2019 30
2020 27
2021 39
2022 34
2023 38
2024 19

Text availability

Article attribute

Article type

Publication date

PubMed for id: 1778124

500 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 randomized trial of mavorixafor, CXCR4 antagonist, in WHIM syndrome.
Badolato R, Alsina L, Azar A, Bertrand Y, Bolyard AA, Dale DC, Deyà-Martinez À, Dickerson KE, Ezra N, Hasle H, Kang HJ, Kiani-Alikhan S, Kuijpers TW, Kulagin A, Langguth D, Levin C, Neth O, Olbrich P, Peake J, Rodina Y, Rutten CE, Shcherbina A, Tarrant TK, Vossen MG, Wysocki CA, Belschner A, Bridger GJ, Chen K, Dubuc S, Hu Y, Jiang H, Li S, MacLeod R, Stewart M, Taveras AG, Yan T, Donadieu J. Badolato R, et al. Blood. 2024 Apr 21:blood.2023022658. doi: 10.1182/blood.2023022658. Online ahead of print. Blood. 2024. PMID: 38643510
CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
Moulin C, Beaupain B, Suarez F, Bertrand Y, Beaussant SC, Fischer A, Durin J, Ranta D, Espéli M, Bachelerie F, Bellanné-Chantelot C, Molina T, Emile JF, Balabanian K, Deback C, Donadieu J. Moulin C, et al. Br J Haematol. 2024 Apr;204(4):1383-1392. doi: 10.1111/bjh.19373. Epub 2024 Mar 5. Br J Haematol. 2024. PMID: 38442908
Comparison of PM2.5 Air Pollution Exposures and Health Effects Associations Using 11 Different Modeling Approaches in the Women's Health Initiative Memory Study (WHIMS).
Power MC, Bennett EE, Lynch KM, Stewart JD, Xu X, Park ES, Smith RL, Vizuete W, Margolis HG, Casanova R, Wallace R, Sheppard L, Ying Q, Serre ML, Szpiro AA, Chen JC, Liao D, Wellenius GA, van Donkelaar A, Yanosky JD, Whitsel E. Power MC, et al. Environ Health Perspect. 2024 Jan;132(1):17003. doi: 10.1289/EHP12995. Epub 2024 Jan 16. Environ Health Perspect. 2024. PMID: 38226465 Free PMC article.
Periodontal disease in patients with WHIM syndrome.
Brenchley L, McDermott DH, Gardner PJ, Silva LM, Gao JL, Cho E, Velez D, Moutsopoulos NM, Murphy PM, Fraser D. Brenchley L, et al. J Clin Periodontol. 2024 Apr;51(4):464-473. doi: 10.1111/jcpe.13940. Epub 2024 Jan 7. J Clin Periodontol. 2024. PMID: 38185798
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH, Velez D, Cho E, Cowen EW, DiGiovanna JJ, Pastrana DV, Buck CB, Calvo KR, Gardner PJ, Rosenzweig SD, Stratton P, Merideth MA, Kim HJ, Brewer C, Katz JD, Kuhns DB, Malech HL, Follmann D, Fay MP, Murphy PM. McDermott DH, et al. J Clin Invest. 2023 Oct 2;133(19):e164918. doi: 10.1172/JCI164918. J Clin Invest. 2023. PMID: 37561579 Free PMC article. Clinical Trial.
500 results